PERCEPTIVE ADVISORS LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 5,880,000 4.500% |
3,740,050 (+174.77%) |
Filing |
| 2024-02-14 4:41 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 2,139,950 6.200% |
340,995 (+18.96%) |
Filing |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 1,798,955 5.300% |
-1,128,610 (-38.55%) |
Filing |
| 2022-02-14 5:30 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 2,927,565 9.900% |
1,350,084 (+85.58%) |
Filing |
| 2021-02-16 3:31 pm Purchase |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 1,577,481 6.400% |
250,000 (+18.83%) |
Filing |
| 2020-12-14 08:33 am Purchase |
2020-12-04 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 1,327,481 5.400% |
1,327,481 (New Position) |
Filing |